Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes
出版年份 2013 全文链接
标题
Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 15, Issue 7, Pages 613-621
出版商
Wiley
发表日期
2013-01-28
DOI
10.1111/dom.12073
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dose-Ranging Effects of Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, as Add-On to Metformin in Subjects With Type 2 Diabetes
- (2012) J. Rosenstock et al. DIABETES CARE
- Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin
- (2012) D. Devineni et al. DIABETES OBESITY & METABOLISM
- Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
- (2011) R. Grempler et al. DIABETES OBESITY & METABOLISM
- Role of Chronic and Acute Hyperglycemia in the Development of Diabetes Complications
- (2011) M. Loredana Marcovecchio et al. Diabetes Technology & Therapeutics
- Safety, Pharmacokinetic, and Pharmacodynamic Profiles of Ipragliflozin (ASP1941), a Novel and Selective Inhibitor of Sodium-Dependent Glucose Co-Transporter 2, in Patients with Type 2 Diabetes Mellitus
- (2011) Sherwyn L. Schwartz et al. Diabetes Technology & Therapeutics
- Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
- (2011) Muhammad A. Abdul-Ghani et al. ENDOCRINE REVIEWS
- Management of diabetes across the course of disease: minimizing obesity-associated complications
- (2011) Caroline Apovian Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals With Type 2 Diabetes Mellitus
- (2010) ARCHIVES OF INTERNAL MEDICINE
- Emerging treatment options for type 2 diabetes
- (2010) Milan K. Piya et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Standards of Medical Care in Diabetes--2011
- (2010) DIABETES CARE
- Dapagliflozin: more than just another oral glucose-lowering agent?
- (2010) Niki Katsiki et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Defining and Achieving Treatment Success in Patients With Type 2 Diabetes Mellitus
- (2010) Mark W. Stolar MAYO CLINIC PROCEEDINGS
- Diabetes Prevalence and Therapeutic Target Achievement in the United States, 1999 to 2006
- (2009) Bernard M.Y. Cheung et al. AMERICAN JOURNAL OF MEDICINE
- Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects
- (2009) W. T. CEFALU et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
- (2009) B Komoroski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers: Applicability of a novel insulin-independent treatment
- (2009) J. P.H. Wilding et al. DIABETES CARE
- Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications
- (2009) J. E. Gerich DIABETIC MEDICINE
- Renal sodium–glucose transport: role in diabetes mellitus and potential clinical implications
- (2009) George L. Bakris et al. KIDNEY INTERNATIONAL
- Therapeutic targets to reduce cardiovascular disease in type 2 diabetes
- (2009) Cyrus DeSouza et al. NATURE REVIEWS DRUG DISCOVERY
- Prevalence, Treatment, and Control of Diagnosed Diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004
- (2008) Kwok Leung Ong et al. ANNALS OF EPIDEMIOLOGY
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
- (2008) J. F. List et al. DIABETES CARE
- Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
- (2008) Peter Gæde et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started